J. Schümann, et.al., Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF., Journal of immunology (Baltimore, Md. : 1950), 1998, 161

http://rdf.ncbi.nlm.nih.gov/pubmed/9820556

J. Schümann, et.al., Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF., Journal of immunology (Baltimore, Md. : 1950), 1998, 161

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating tumor necrosis factor level_Foxn1<nu>/Foxn1<nu>
  http://metadb.riken.jp/0008554IBALBcFoxn1nuFoxn1nuFoxn1nu
• decreased circulating alanine transaminase level_Tnfrsf1a<tm1Blt>/Tnfrsf1a<tm1Blt>
  http://metadb.riken.jp/0002942I129Sv129P2OlaHsdC57BL6Tnfrsf1atm1BltTnfrsf1atm1BltTnfrsf1atm1Blt
• decreased interferon-gamma secretion_Foxn1<nu>/Foxn1<nu>
  http://metadb.riken.jp/0008567IBALBcFoxn1nuFoxn1nuFoxn1nu
• decreased susceptibility to bacterial infection_Tnfrsf1a<tm1Blt>/Tnfrsf1a<tm1Blt>
  http://metadb.riken.jp/0002411I129Sv129P2OlaHsdC57BL6Tnfrsf1atm1BltTnfrsf1atm1BltTnfrsf1atm1Blt
• decreased circulating interleukin-6 level_Foxn1<nu>/Foxn1<nu>
  http://metadb.riken.jp/0008597IBALBcFoxn1nuFoxn1nuFoxn1nu
• decreased susceptibility to bacterial infection_Tnfrsf1b<tm1Mwm>/Tnfrsf1b<tm1Mwm>
  http://metadb.riken.jp/0002411I129S2SvPasC57BL6Tnfrsf1btm1MwmTnfrsf1btm1MwmTnfrsf1btm1Mwm
• decreased circulating interleukin-2 level_Foxn1<nu>/Foxn1<nu>
  http://metadb.riken.jp/0008600IBALBcFoxn1nuFoxn1nuFoxn1nu
• decreased circulating alanine transaminase level_Prf1<tm1Tsc>/Prf1<tm1Tsc>
  http://metadb.riken.jp/0002942I129S2SvPasPrf1tm1TscPrf1tm1TscPrf1tm1Tsc
• decreased circulating alanine transaminase level_Foxn1<nu>/Foxn1<nu>
  http://metadb.riken.jp/0002942IBALBcFoxn1nuFoxn1nuFoxn1nu
• decreased susceptibility to bacterial infection_Foxn1<nu>/Foxn1<nu>
  http://metadb.riken.jp/0002411IBALBcFoxn1nuFoxn1nuFoxn1nu
• increased sensitivity to induced morbidity/mortality_Fas<lpr>/Fas<lpr>
  http://metadb.riken.jp/0009763IMRLMpFaslprFaslprFaslpr
• abnormal circulating cytokine level_Foxn1<nu>/Foxn1<nu>
  http://metadb.riken.jp/0010210IBALBcFoxn1nuFoxn1nuFoxn1nu
• increased susceptibility to bacterial infection_Fas<lpr>/Fas<lpr>
  http://metadb.riken.jp/0002412IMRLMpFaslprFaslprFaslpr
• decreased susceptibility to bacterial infection_Prf1<tm1Tsc>/Prf1<tm1Tsc>
  http://metadb.riken.jp/0002411I129S2SvPasPrf1tm1TscPrf1tm1TscPrf1tm1Tsc

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating tumor necrosis factor level in RBRC00192
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000569
• abnormal circulating cytokine level in RBRC00135
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016863
• decreased susceptibility to bacterial infection in RBRC00135
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016813
• abnormal circulating cytokine level in RBRC00206
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016952
• decreased circulating tumor necrosis factor level in RBRC00012
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000098
• decreased circulating interleukin-6 level in RBRC00135
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016850
• decreased circulating interleukin-6 level in RBRC00357
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021450
• abnormal circulating cytokine level in RBRC03120
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005693
• decreased circulating tumor necrosis factor level in RBRC01676
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003044
• abnormal circulating cytokine level in RBRC00692
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001138
• decreased circulating interleukin-2 level in RBRC00175
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000484
• decreased circulating tumor necrosis factor level in RBRC00356
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021410
• decreased circulating alanine transaminase level in RBRC00106
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000254
• abnormal circulating cytokine level in RBRC00330
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017037
• decreased circulating alanine transaminase level in RBRC02778
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020732
• decreased interferon-gamma secretion in RBRC00106
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000272
• decreased susceptibility to bacterial infection in RBRC00192
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000547
• increased sensitivity to induced morbidity/mortality in RBRC02885
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005247
• decreased circulating interleukin-6 level in RBRC00330
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017027
• decreased circulating interleukin-2 level in RBRC03120
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005684
• decreased circulating tumor necrosis factor level in RBRC02778
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020762
• decreased interferon-gamma secretion in RBRC00356
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021411
• decreased circulating interleukin-2 level in RBRC00206
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016943
• abnormal circulating cytokine level in RBRC02778
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020777
• decreased circulating interleukin-2 level in RBRC01676
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003047
• decreased circulating interleukin-6 level in RBRC00192
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000571
• decreased circulating interleukin-2 level in RBRC02778
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020765
• decreased interferon-gamma secretion in RBRC03120
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005682
• decreased interferon-gamma secretion in RBRC00692
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001127
• decreased circulating alanine transaminase level in RBRC00192
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000552
• decreased circulating interleukin-6 level in RBRC00175
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000483
• decreased interferon-gamma secretion in RBRC00135
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016849
• increased sensitivity to induced morbidity/mortality in RBRC06464
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010090
• increased susceptibility to bacterial infection in RBRC03105
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010668
• decreased interferon-gamma secretion in RBRC00012
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000099
• decreased circulating alanine transaminase level in RBRC00206
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016921
• increased susceptibility to bacterial infection in RBRC06798
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010871
• decreased circulating interleukin-6 level in RBRC00206
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016942
• increased sensitivity to induced morbidity/mortality in RBRC02442
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1004581
• decreased circulating interleukin-6 level in RBRC00106
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000273
• decreased circulating interleukin-2 level in RBRC00012
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000101
• abnormal circulating cytokine level in RBRC00357
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021454
• decreased interferon-gamma secretion in RBRC00175
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000482
• decreased circulating interleukin-2 level in RBRC00135
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016851
• decreased circulating alanine transaminase level in RBRC00356
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021403
• decreased circulating interleukin-2 level in RBRC00330
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017028
• abnormal circulating cytokine level in RBRC00175
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000493
• decreased interferon-gamma secretion in RBRC00357
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021449
• decreased circulating alanine transaminase level in RBRC00330
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017007
• decreased circulating tumor necrosis factor level in RBRC00330
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017025
• decreased circulating alanine transaminase level in RBRC00012
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000081
• decreased circulating interleukin-2 level in RBRC00192
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000572
• decreased susceptibility to bacterial infection in RBRC00175
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000459
• decreased susceptibility to bacterial infection in RBRC00692
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001104
• increased susceptibility to bacterial infection in RBRC02442
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010548
• decreased circulating interleukin-6 level in RBRC00692
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001128
• abnormal circulating cytokine level in RBRC00192
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000581
• increased sensitivity to induced morbidity/mortality in RBRC02886
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005350
• decreased circulating alanine transaminase level in RBRC01676
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003027
• decreased interferon-gamma secretion in RBRC00206
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016941
• abnormal circulating cytokine level in RBRC00012
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000110
• decreased circulating alanine transaminase level in RBRC00357
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021441
• decreased interferon-gamma secretion in RBRC01676
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003045
• increased sensitivity to induced morbidity/mortality in RBRC03105
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005597
• decreased circulating interleukin-6 level in RBRC00012
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000100
• decreased susceptibility to bacterial infection in RBRC03120
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005659
• decreased circulating tumor necrosis factor level in RBRC00175
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000481
• decreased susceptibility to bacterial infection in RBRC00356
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021401
• decreased circulating alanine transaminase level in RBRC00175
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000464
• decreased susceptibility to bacterial infection in RBRC00357
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021439
• decreased circulating alanine transaminase level in RBRC00135
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016819
• decreased circulating tumor necrosis factor level in RBRC00357
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021448
• abnormal circulating cytokine level in RBRC01676
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003056
• decreased susceptibility to bacterial infection in RBRC00012
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000076
• increased susceptibility to bacterial infection in RBRC06464
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010849
• increased susceptibility to bacterial infection in RBRC02886
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010647
• decreased susceptibility to bacterial infection in RBRC02778
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020726
• increased susceptibility to bacterial infection in RBRC02885
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010626
• decreased circulating tumor necrosis factor level in RBRC00106
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000271
• decreased susceptibility to bacterial infection in RBRC00330
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017002
• decreased interferon-gamma secretion in RBRC00330
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1017026
• decreased circulating interleukin-2 level in RBRC00106
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000274
• decreased circulating interleukin-6 level in RBRC03120
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005683
• decreased circulating interleukin-6 level in RBRC02778
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020764
• decreased susceptibility to bacterial infection in RBRC00106
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000249
• decreased circulating interleukin-2 level in RBRC00356
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021413
• decreased interferon-gamma secretion in RBRC00192
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000570
• decreased circulating tumor necrosis factor level in RBRC00206
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016940
• decreased circulating alanine transaminase level in RBRC00692
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001109
• decreased circulating tumor necrosis factor level in RBRC03120
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005681
• decreased circulating tumor necrosis factor level in RBRC00135
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016848
• decreased circulating tumor necrosis factor level in RBRC00692
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001126
• decreased circulating alanine transaminase level in RBRC03120
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1005664
• decreased circulating interleukin-2 level in RBRC00692
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1001129
• decreased susceptibility to bacterial infection in RBRC00206
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016916
• abnormal circulating cytokine level in RBRC00106
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1000283
• decreased susceptibility to bacterial infection in RBRC01676
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003022
• abnormal circulating cytokine level in RBRC00356
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021416
• decreased circulating interleukin-6 level in RBRC01676
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1003046
• decreased circulating interleukin-2 level in RBRC00357
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021451
• decreased interferon-gamma secretion in RBRC02778
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1020763
• decreased circulating interleukin-6 level in RBRC00356
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1021412
• increased sensitivity to induced morbidity/mortality in RBRC06798
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1010206